A gather of experts shared their insights on genetic testing and stepping towards Precision Oncology to an audience of over 160 participants, from doctors, geneticists, to policymakers from the Department of Health on March 20, 2018. Dr. Ava Kwong shared the local data from HK Hereditary Breast Cancer Family Registry to demonstrate the importance of genetic testing not only for prevention and early diagnosis but also therapeutic guidance.
Participated experts:
Dr. Au Siu-Kie Joseph
Specialist in Clinical Oncology, Hong Kong Adventist Hospital
Dr. Ava Kwong
Chief of Breast Surgery Division, Clinical Associate Professor, the University of Hong Kong
Honorary Consultant, Hong Kong Sanatorium and Hospital
Chairman, Hong Kong Hereditary Breast Cancer Family Registry
Dr. Chen Shu-Jen
Chief Scientific Officer, ACT Genomics
Dr Chow Yat-Ngok York
Chief Medical Officer & Corporate Advisor of AIA Hong Kong & Macau
Dr. Lam Tak-Sum Stephen
Director, Clinical Genetics Service, Hong Kong Sanatorium & Hospital
Dr. Lee Soo-Chin
Chief and Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore
Prof. Lee Wing-Mui Anne
Head of Department, Department of Clinical Oncology, LKS Faculty of Medicine, the University of Hong Kong
Prof. Leung Suet-Yi
Associate Dean(Research), YW Kan Professor in Natural Sciences, Chair of Gastrointestinal Cancer Genetics and Genomics
Department of Pathology, LKS Faculty of Medicine, the University of Hong Kong
Prof. Liang Hin-Suen Raymond
Emeritus Professor, Department of Medicine, LKS Faculty of Medicine, the University of Hong Kong
Dr. Lo Fai-Man Ivan
Chairman of the Hong Kong Society of Medical Genetics
